$CERS
CERUS CORP

2020 Q2 Form 10-Q Financial Statement

#000156459020036218 Filed on August 04, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2020 Q1
Revenue $26.83M $24.64M
YoY Change 19.35% 12.15%
Cost Of Revenue $9.710M $8.320M
YoY Change 19.71% -1.3%
Gross Profit $17.12M $16.32M
YoY Change 19.22% 20.62%
Gross Profit Margin 63.81% 66.23%
Selling, General & Admin $16.11M $15.91M
YoY Change -3.76% -1.53%
% of Gross Profit 94.1% 97.51%
Research & Development $15.62M $15.81M
YoY Change 8.32% 17.63%
% of Gross Profit 91.24% 96.88%
Depreciation & Amortization $780.0K $706.0K
YoY Change -33.9% 87.77%
% of Gross Profit 4.56% 4.33%
Operating Expenses $31.73M $31.72M
YoY Change 89.55% 7.17%
Operating Profit -$14.61M -$15.40M
YoY Change 513.87% -4.16%
Interest Expense -$660.0K -$1.160M
YoY Change -37.14% -62.46%
% of Operating Profit
Other Income/Expense, Net $460.0K $150.0K
YoY Change -164.97% -64.29%
Pretax Income -$14.80M -$16.41M
YoY Change -15.43% -12.39%
Income Tax $70.00K $57.00K
% Of Pretax Income
Net Earnings -$14.87M -$16.47M
YoY Change -15.32% -12.38%
Net Earnings / Revenue -55.43% -66.83%
Basic Earnings Per Share
Diluted Earnings Per Share -$90.46K -$104.6K
COMMON SHARES
Basic Shares Outstanding 162.2M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $136.5M $133.1M
YoY Change 41.89% 32.57%
Cash & Equivalents $34.90M $36.12M
Short-Term Investments $101.6M $99.40M
Other Short-Term Assets $6.500M $5.400M
YoY Change -26.14% 8.0%
Inventory $18.43M $21.68M
Prepaid Expenses
Receivables $17.60M $18.20M
Other Receivables $0.00 $0.00
Total Short-Term Assets $179.0M $178.3M
YoY Change 31.78% 32.17%
LONG-TERM ASSETS
Property, Plant & Equipment $28.30M $28.70M
YoY Change 84.42% -9.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.414M $6.900M
YoY Change -8.08% -10.39%
Total Long-Term Assets $36.49M $37.10M
YoY Change -5.92% -9.51%
TOTAL ASSETS
Total Short-Term Assets $179.0M $178.3M
Total Long-Term Assets $36.49M $37.10M
Total Assets $215.5M $215.4M
YoY Change 23.4% 22.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.83M $20.20M
YoY Change -10.58% -3.35%
Accrued Expenses $16.87M $17.20M
YoY Change 1.27% -14.01%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $5.000M $4.800M
YoY Change 11.11%
Total Short-Term Liabilities $43.10M $45.10M
YoY Change -15.13% -5.24%
LONG-TERM LIABILITIES
Long-Term Debt $39.50M $39.50M
YoY Change 0.51% 0.25%
Other Long-Term Liabilities $713.0K $18.40M
YoY Change 334.76% 20809.09%
Total Long-Term Liabilities $713.0K $57.90M
YoY Change 334.76% 65695.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $43.10M $45.10M
Total Long-Term Liabilities $713.0K $57.90M
Total Liabilities $101.0M $103.0M
YoY Change -7.36% -3.22%
SHAREHOLDERS EQUITY
Retained Earnings -$881.4M
YoY Change 8.12%
Common Stock $994.8M
YoY Change 12.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $114.5M $112.4M
YoY Change
Total Liabilities & Shareholders Equity $215.5M $215.4M
YoY Change 23.4% 22.44%

Cashflow Statement

Concept 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income -$14.87M -$16.47M
YoY Change -15.32% -12.38%
Depreciation, Depletion And Amortization $780.0K $706.0K
YoY Change -33.9% 87.77%
Cash From Operating Activities -$7.810M -$19.80M
YoY Change -39.36% -10.71%
INVESTING ACTIVITIES
Capital Expenditures -$460.0K $452.0K
YoY Change -85.62% -86.37%
Acquisitions
YoY Change
Other Investing Activities -$1.140M -$49.73M
YoY Change -7.32% -401.39%
Cash From Investing Activities -$1.590M -$50.19M
YoY Change -64.11% -480.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $67.70M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.65M 68.68M
YoY Change -9.82% 652.04%
NET CHANGE
Cash From Operating Activities -7.810M -19.80M
Cash From Investing Activities -1.590M -50.19M
Cash From Financing Activities 10.65M 68.68M
Net Change In Cash 1.250M -1.303M
YoY Change -122.73% -1030.71%
FREE CASH FLOW
Cash From Operating Activities -$7.810M -$19.80M
Capital Expenditures -$460.0K $452.0K
Free Cash Flow -$7.350M -$20.25M
YoY Change -24.07% -20.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Goodwill
Goodwill
1316000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14122000
us-gaap Revenue Practical Expedient Remaining Performance Obligation
RevenuePracticalExpedientRemainingPerformanceObligation
true
CY2020Q2 us-gaap Liabilities
Liabilities
100969000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31213000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-881448000
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94520
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Assets
Assets
215494000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
18831000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
994682000
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
166000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16865000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17611000
CY2020Q2 us-gaap Secured Debt Current
SecuredDebtCurrent
4950000
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 600
dei Entity Address City Or Town
EntityAddressCityOrTown
Concord
dei City Area Code
CityAreaCode
925
dei Local Phone Number
LocalPhoneNumber
288-6000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
114525000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
215494000
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
31000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1125000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18025000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
713000
cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
22089000
us-gaap Operating Expenses
OperatingExpenses
63453000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
50000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
124000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
132000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4524000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13768000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2435000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4414000
CY2019Q4 us-gaap Assets
Assets
165535000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
22185000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20951000
cers Product Warranty Term
ProductWarrantyTerm
P1Y
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36233000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2460000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1613000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16543000
cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
19170000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
32901000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3372000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
121000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
50732000
CY2019Q4 us-gaap Inventory Net
InventoryNet
19490000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
128108000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14898000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16882000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34986000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6018000
us-gaap Net Income Loss
NetIncomeLoss
-31337000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
us-gaap Net Income Loss
NetIncomeLoss
-36354000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
160894000
CY2020Q1 cers Issuance Of Common Stock From Exercise Of Stock Options Or Warrants And Vesting Of Restricted Stock Units And Employee Stock Purchase Plans Purchases Value
IssuanceOfCommonStockFromExerciseOfStockOptionsOrWarrantsAndVestingOfRestrictedStockUnitsAndEmployeeStockPurchasePlansPurchasesValue
1193000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-237000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-16466000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35982000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51780000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2797000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1270000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
76595000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6783000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
500000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
570000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
50336000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20588000
CY2019Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
39414000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18406000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
144000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
906905000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
114000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-850111000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
57052000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
165535000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24225000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
57052000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
112408000
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
9429000
CY2020Q2 cers Issuance Of Common Stock From Exercise Of Stock Options Or Warrants And Vesting Of Restricted Stock Units Value
IssuanceOfCommonStockFromExerciseOfStockOptionsOrWarrantsAndVestingOfRestrictedStockUnitsValue
1605000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4706000
cers Non Cash Operating Lease Cost
NonCashOperatingLeaseCost
-796000
us-gaap Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
-261000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-14000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1248000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-14871000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
114525000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
84519000
CY2019Q1 cers Issuance Of Common Stock From Exercise Of Stock Options Or Warrants And Vesting Of Restricted Stock Units And Employee Stock Purchase Plans Purchases Value
IssuanceOfCommonStockFromExerciseOfStockOptionsOrWarrantsAndVestingOfRestrictedStockUnitsAndEmployeeStockPurchasePlansPurchasesValue
684000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2878000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
211000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-18792000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
69500000
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
9836000
CY2019Q2 cers Issuance Of Common Stock From Exercise Of Stock Options Or Warrants And Vesting Of Restricted Stock Units Value
IssuanceOfCommonStockFromExerciseOfStockOptionsOrWarrantsAndVestingOfRestrictedStockUnitsValue
558000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3139000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
161000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-17562000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
65632000
us-gaap Profit Loss
ProfitLoss
-31337000
us-gaap Profit Loss
ProfitLoss
-36354000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1488000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1112000
us-gaap Share Based Compensation
ShareBasedCompensation
8460000
us-gaap Share Based Compensation
ShareBasedCompensation
6017000
cers Non Cash Operating Lease Cost
NonCashOperatingLeaseCost
-619000
cers Non Cash Interest Expense
NonCashInterestExpense
237000
cers Non Cash Interest Expense
NonCashInterestExpense
247000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
742000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4680000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-962000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3977000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-140000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1817000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3186000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3229000
cers Increase Decrease In Accrued Liabilities And Other Noncurrent Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherNoncurrentLiabilities
-4644000
cers Increase Decrease In Accrued Liabilities And Other Noncurrent Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherNoncurrentLiabilities
-3410000
cers Increase Decrease In Manufacturing And Development Payment Liability
IncreaseDecreaseInManufacturingAndDevelopmentPaymentLiability
-38000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
136000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
167000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27606000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35060000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
907000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6516000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
76871000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
27728000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
25998000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
43000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8756000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-67000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
4496000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
39433000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-61000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37421000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31587000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, management evaluates its estimates, including those related to the nature and timing of satisfaction of performance obligations, the timing when the customer obtains control of products or services, the standalone selling price (“SSP”) of performance obligations, variable consideration, accounts receivable, inventory reserves, fair values of investments, the allowance for credit losses, stock-based compensation, intangible assets and goodwill, useful lives of intangible assets and property and equipment, income taxes, accrued liabilities, and incremental borrowing rate, among others. The Company bases its estimates on historical experience, future projections, and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from those estimates under different assumptions or conditions.</p>
us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
The Company invoices its customers based upon the terms in the contracts, which generally requires payment 30 to 60 days from the date of invoice.
CY2020Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2019Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, available-for-sale securities and accounts receivable.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the Company’s investment policy, substantially all of the Company’s cash, cash equivalents and available-for-sale securities are maintained at major financial institutions of high credit standing. The Company monitors the financial credit worthiness of the issuers of its investments and limits the concentration in individual securities and types of investments that exist within its investment portfolio. Generally, all of the Company’s investments carry high credit quality ratings, which is in accordance with its investment policy. At June 30, 2020, the Company does not believe there is significant financial risk from non-performance by the issuers of the Company’s cash equivalents and short-term investments.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of credit risk with respect to trade receivables exist. On a regular basis, including at the time of sale, the Company performs credit evaluations of its significant customers that it expects to sell to on credit terms. Generally, the Company does not require collateral from its customers to secure accounts receivable. To the extent that the Company determines specific invoices or customer accounts may be uncollectible, the Company establishes an allowance for doubtful accounts against the accounts receivable on its condensed consolidated balance sheets and records a charge on its condensed consolidated statements of operations as a component of selling, general and administrative expenses.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company had two customers and three customers that accounted for more than 10% of the Company’s outstanding trade receivables at June 30, 2020 and December 31, 2019, respectively. These customers cumulatively represented approximately 47% and 56% of the Company’s outstanding trade receivables at June 30, 2020 and December 31, 2019, respectively. To date, the Company has not experienced collection difficulties from these customers.</p>
CY2020Q2 cers Cumulative Outstanding Trade Receivables Number Of Major Customers
CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers
2
CY2019Q4 cers Cumulative Outstanding Trade Receivables Number Of Major Customers
CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers
3
cers Work In Process Inventory Life Period
WorkInProcessInventoryLifePeriod
P1Y
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
100000
CY2020Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
100000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
300000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2900000
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P10Y
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2000000.0
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1900000
CY2020Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2019Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
23227000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20248000
CY2020Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
0
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
0
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
116233000
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1128000
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3000
CY2020Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
117358000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
59478000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
114000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
59592000
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
117358000
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
66372000
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
66766000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
43822000
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
49861000
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
50592000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
15656000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
15685000
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
116233000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
59478000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
59592000
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
0
CY2020Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2019Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2019Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2020Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2020Q2 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
300000
CY2019Q2 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0
CY2019Q2 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
117358000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
59592000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12703000
CY2020Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3655000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3489000
CY2020Q2 cers Accrued Development Costs Current
AccruedDevelopmentCostsCurrent
1358000
CY2020Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4540000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5160000
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
13885000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
14330000
CY2020Q2 us-gaap Inventory Net
InventoryNet
18425000
CY2019Q4 us-gaap Inventory Net
InventoryNet
19490000
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9136000
CY2019Q4 cers Accrued Development Costs Current
AccruedDevelopmentCostsCurrent
1468000
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2716000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3291000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16865000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20951000
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.089
cers Minimum Term Of Non Cancelable Operating Leases
MinimumTermOfNonCancelableOperatingLeases
P1Y
cers Expiration Of Non Cancelable Operating Leases Maximum Year
ExpirationOfNonCancelableOperatingLeasesMaximumYear
2030
us-gaap Operating Lease Payments
OperatingLeasePayments
1765000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
265000
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y9M18D
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1635000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3460000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2937000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2793000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2711000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
16052000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
29588000
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10184000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
19404000
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
839000
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
912000
us-gaap Operating Lease Cost
OperatingLeaseCost
1663000
us-gaap Operating Lease Cost
OperatingLeaseCost
1458000
us-gaap Lessor Operating Lease Lease Not Yet Commenced Description
LessorOperatingLeaseLeaseNotYetCommencedDescription
the Company had no leases that have not yet commenced.
CY2020Q2 cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
6300000
CY2019Q2 cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
5600000
cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
14400000
cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
13400000
CY2020Q2 cers Accrual For Manufacturing Of Entity Products
AccrualForManufacturingOfEntityProducts
7825000
CY2019Q4 cers Accrual For Manufacturing Of Entity Products
AccrualForManufacturingOfEntityProducts
8470000
CY2020Q2 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
2632000
CY2019Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
1796000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1

Files In Submission

Name View Source Status
0001564590-20-036218-index-headers.html Edgar Link pending
0001564590-20-036218-index.html Edgar Link pending
0001564590-20-036218.txt Edgar Link pending
0001564590-20-036218-xbrl.zip Edgar Link pending
cers-10q_20200630.htm Edgar Link pending
cers-10q_20200630_htm.xml Edgar Link completed
cers-20200630.xsd Edgar Link pending
cers-20200630_cal.xml Edgar Link unprocessable
cers-20200630_def.xml Edgar Link unprocessable
cers-20200630_lab.xml Edgar Link unprocessable
cers-20200630_pre.xml Edgar Link unprocessable
cers-ex101_139.htm Edgar Link pending
cers-ex102_140.htm Edgar Link pending
cers-ex103_141.htm Edgar Link pending
cers-ex104_142.htm Edgar Link pending
cers-ex311_8.htm Edgar Link pending
cers-ex312_7.htm Edgar Link pending
cers-ex321_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g442lyfum1ku000001.jpg Edgar Link pending
g442lyfum1ku000002.jpg Edgar Link pending
g442lyfum1ku000003.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending